Article Topic
Complaint, USA v Oluwole Adegboruwa, May 2019
United States District Court District of Utah USA v Oluwole Adegboruwa Complaint Filed May 16, 2019 Read the document.
[...]July 29, 2024: FDA issued new alert about compounded semaglutide
The FDA warns that patients are harming themselves using compounded semaglutide. Cases involving pill presses in two U.S. states and two other countries.
[...]FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products
FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products.
[...]Amended Jury Instructions, USA v Rahim Shafa et al, February 2024
United States District Court District of Massachusetts USA v Rahim Shafa et al Amended Jury Instructions Filed February 5, 2024 Read the document.
[...]Government’s Sentencing Position, USA v Wayne Moran, March 2018
United States District Court Central District of California USA v Wayne Moran Government’s Sentencing Position Filed August 16, 2022 Read the document.
[...]Government’s Sentencing Memo, USA v Nerik Ilyayev, April 2024
United States District Court Southern District of New York USA v Nerik Ilyayev Government’s Sentencing Memo Filed April 11, 2024 Read the document.
[...]Indictment, USA v Adam Brosius, Patrick Boyd and Charles Boyd, June 2024
United States District Court Southern District of Florida USA v Adam Brosius, Patrick Boyd and Charles Boyd Indictment Filed June 20, 2024 Read the document.
[...]July 22, 2024: A Michigan pharmacy sues supplier over fake Ozempic
A Michigan company is suing a telepharmacy that allegedly supplied fake Ozempic. New resources about the risks of compounded medicines. Details about the fake cancer drug ring busted in India.
[...]Patients face safety risks with counterfeit and compounded prescription weight-loss drugs
Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges. Demand is skyrocketing for FDA-approved medicines that provide incredible benefits to patients living with diabetes and obesity. The injectables – GLP-1s like semaglutide and incretins that are commonly known as…
[...]July 15, 2024: What some fake Botox victims have endured
New information on the patients recently hurt by counterfeit Botox, two news stories involving pill presses, and a prosecution announced in Austria over fake Ozempic that sent multiple people to the hospital.
[...]